Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Nachum, Z., Shupak, A. & Gordon, C. R. Transdermal scopolamine for prevention of motion sickness. Clinical Pharmacokinetics and Therapeutic Applications 45, 543–566 (2006).
2. Braida, D. et al. Role of neuronal nicotinic acetylcholine receptors (nSChRs) on learning and memory in zebrafish. Psychopharmacology. 231, 1975–1985 (2014).
3. Klinkenberg, I. & Blokland, A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neuroscience & Biobehavioral Reviews 34, 1307–1350 (2010).
4. Furey, M. L. & Drevets, W. C. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 63, 1121–1129 (2006).
5. Furey, M. L., Khanna, A., Hoffman, E. M. & Drevets, W. C. Scopolamine produces larger antidepressant and antianxiety effects in women than in men. Neuropsychopharmacology 35, 2479–2488 (2010).
Cited by
75 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献